Posted on November 17th, 2009 by Health News
A woman who suffers sudden cardiac arrest is significantly less likely than a man to exhibit the decrease in the heart’s pumping ability that is widely recognized as a precursor, says a new study in the Nov. 24 Journal of the American College of Cardiology. The lack of left ventricular dysfunction could mean [...]
No Comments »
Filed under: Women's Health
Posted on November 17th, 2009 by Health News
ORLANDO (MedPage Today) — The use of surrogate endpoints allows researchers to quickly get answers to clinical questions in well-designed, but relatively small studies — but, as this exclusive InFocus™ report shows — their use is not without controversy.
No Comments »
Filed under: General Health News
Posted on November 17th, 2009 by Health News
Hand-held computers and decision-support software improved diagnostic decision making for suspected pulmonary embolism, French researchers said.
No Comments »
Filed under: Pharmacy News
Posted on November 17th, 2009 by Health News
The FDA has received several reports of chondrolysis after continuous intra-articular infusions of local anesthetics with elastomeric infusion devices.
No Comments »
Filed under: Pharmacy News
Posted on November 17th, 2009 by Health News
The FDA has okayed tranexamic acid tablets (Lysteda) for the treatment of menorrhagia, the agency announced.
No Comments »
Filed under: Pharmacy News
Posted on November 17th, 2009 by Health News
Oncolytics Biotech Inc. today announced updated results from a Phase I/II U.K. trial (REO 011) of REOLYSIN(R) combined with paclitaxel/carboplatin for patients with advanced cancers in a poster presentation at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference being held in Boston, Massachusetts.
No Comments »
Filed under: Pharmacy News
Posted on November 17th, 2009 by Health News
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd [...]
No Comments »
Filed under: Pharmacy News
Posted on November 17th, 2009 by Health News
YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, announced that preclinical results for CYT997 were presented today in a poster by Cytopia Limited at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, Massachusetts.
No Comments »
Filed under: Pharmacy News
Posted on November 17th, 2009 by Health News
Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria. The study will evaluate the safety, tolerability and pharmacokinetics of AN3365 in healthy volunteers.
No Comments »
Filed under: Pharmacy News
Posted on November 17th, 2009 by Health News
ThromboGenics NV and BioInvent International AB today announced positive results from a Phase I trial of their novel anti-cancer monoclonal antibody TB-403 in patients with advanced solid tumours. The results were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, U.S. TB-403 was well tolerated with no reported dose limiting [...]
No Comments »
Filed under: Pharmacy News
